Medical management: From colony to community  by Aldenkamp, Albert P.
Seizure 19 (2010) 625–627Short survey
Medical management: From colony to community
Albert P. Aldenkamp a,b,c,*
aDepartment of Behavioural Science, Research Institute of the Epilepsy Centre Kempenhaeghe, Heeze, Netherlands
bDepartment of Neurology, Maastricht University Medical Centre, Maastricht, Netherlands
c Epilepsy Research Group, Research School Mental Health & Neurosciences, Maastricht University, Maastricht, Netherlands





A B S T R A C T
In this article the development from the colonies founded in the 19th century to the current situation is
discussed. Future development is not to simply follow the slogan ‘to the community’ translated as
‘epilepsy must be treated in general hospitals’ but to preserve epileptology as specialized care with
‘centres of excellence’ orchestrated by coupling epilepsy centres with academical neurology.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy care and cure have shown a substantial development
over the past 60 years and this may be summarized by the title of
this contribution: ‘from colony to community’. When evaluating
this development it is imperative to distinguish care and cure:
care for those with chronic refractory epilepsy and cure for those
patients that beneﬁt from treatment and generally will only have
epileptic seizures during a part of their life. The care for patients
with chronic epilepsy is often complicated by learning disability.
A separate group are those patients with difﬁcult-to-treat
epilepsies but who can beneﬁt from available invasive treatment
techniques such as epilepsy surgery or deep brain stimulation.
When assessing developments over time it is also necessary to
make a distinction between care and cure for children and adults.
This all implies that it is unwise to speak in too general terms such
as ‘patientswith epilepsy’. The situation is a farmore complex one
than that phrase implies.
2. The beginning: the time of the colonies
Epilepsy centres started their lives as ‘colonies’: large facilities,
often outside the community in rural areas. Most of the epilepsy
centres were founded in the late 19th century, often started by a
few people and driven by Christian ideals of providing care and
offering dignity. The history of these centres is parallel to that of
the asylummovement, which originated at the same time for those
with incurable mental illness.1 Like the asylums of the late* Correspondence address: Department of Behavioural Science, Research
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where the afﬂicted were protected from stigmatising public view.
It is important to realize that in the periods of foundation of the
colonies no other treatments for epilepsy than bromide were
available. Labour and fresh air were considered important
treatments.
Four examples to illustrate the origins and developments of
such centres:
- Anstalt Bethel, Bielfeld, Germany was founded in 1867 by pious
merchants and salesmen. It is a non-governmental foundation
with a Christian background. Originally long-term residential
care was not an aim. Pedagogues had a dominant position in the
centre and the ﬁrst headwas a teacher. In later years when it was
discovered that few patients could be discharged and return to
home, the concept of ‘colony’ was developed. Consequently not
only people with epilepsy but also others, such as homeless,
elderly and psychiatric patients were housed there. This is still
the structure of the organization, with 7000 places and 11,000
staff members. Within this complex organization, Mara, an
epilepsy hospital, was inaugurated in 1933 when facilities for
treatment expanded. Nowadays the philosophy is one of
comprehensive care, with an epilepsy clinic of about 100 beds,
a unit for surgery (14 beds), vocational training, out-patient
counseling (4000 visits annually), residential units (for 500
persons), sheltered workshops and a society for research. The
epilepsy centre constitutes about 25% of the total centre.
- The Chalfont centre for Epilepsy also has an interesting
background. The National Hospital for the Paralysed and Epileptic
was founded at Queen Square, London, in 1857. The Hospital has
since been renamed The National Hospital for Neurology and
Neurosurgery, which included famous pioneers of neurology and
epileptology such as Gowers and Jackson. The National Society forvier Ltd. All rights reserved.
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farm in Chalfont, Buckinghamshire in 1894. The name of the
society was changed to the National Society for Epilepsy (NSE) in
1907. The NSE has provided residential care and public education
from that time at the Chalfont site. In 1983, a unique tripartite
arrangement was established between charity (NSE), university
(Institute of Neurology of University College London) and hospital
(The National Hospital for Neurology and Neurosurgery). This
developed through continuous cooperation (for example by joint
appointments) into a comprehensive spectrumof clinical care and
research at the Chalfont and Queen Square sites.
- The Swiss Epilepsy Centre was founded in 1886 by a private
association with Christian motives. They founded a place of
refuge and healing for ‘epileptics’. Until the 1950s the centre
functioned as an asylum run on Christian principles. In the 1960s
the institute underwent a phase of modernisation and physio-
therapy, vocational training, psychology, etc. were introduced.
The basic approach is now one of interdisciplinary collaboration.
It has a hospital unit with 44 beds and a residential unit with 177
beds. There is an expanding cooperation with the University
Hospital in Zurich.
- The Dutch epilepsy centre, Kempenhaeghe, was founded in 1919
by the Brothers of theHoly Joseph andwas originally intended for
nursing male epileptics. A monastery was built for this purpose,
called Providentia. In 1953, the medical director of Providentia
and the Dean of the village Heeze decided to build a parallel
institution for female epileptics. This was run by the Congrega-
tion of Franciscan Nuns. After merging of the initiatives in 1971 a
new foundation, ‘Kempenhaeghe’, became the legal body that
administers the epilepsy centre at both locations. Currently the
centre has out-patient facilities (about 15,000 visits annually),
about 80 hospital beds, and a residential area with about 300
beds. There is also a large school. There is a close collaboration
with the Maastricht University Medical Centre.
3. Development over time
Over the many decades that the epilepsy centres have existed,
their role, position and services have changed considerably.
However, the large epilepsy centres still show some similarities.
They offer both ambulatory and inpatient care; they have
assessment units (short stay hospital facilities), as well as a large
number of beds (most centres have several hundreds) for residents
with refractory epilepsy (long stay, residential care). The centres
consider themselves as ‘Centres of Excellence’ or ‘Centres of
Competence’ offering state-of-the-art multidisciplinary care. Some
of these centres base this position on the facilities they offer, others
also on a research portfolio that is coupled to patient care.
Since 2001 a European Association of Epilepsy Centres exists of
which the founding members were: Epilepsiezentrum Bethel in
Bielefeld, Germany; Kolonien Filadelﬁa, Dianalund in Denmark;
Meer & Bosch, Heemstede, the Netherlands; Epilepsiecentrum
Kempenhaeghe, Heeze, The Netherlands; Diakonie Kork Epilep-
siezentrum, Kork, Germany; National Society for Epilepsy at the
Chalfont centre, London, England; Spesialsykehuset for epilepsy,
Sandvika, Norway; Etablissement Medical de la Teppe, Tain
L’Hermitage, France; Schweizerisches EpilepsieZentrum, Zurich,
Switzerland.2
It is difﬁcult to provide a similar list for other areas in the world.
Epilepsy centres, as deﬁned above, are typically European institu-
tions. Elsewhere in the world care is provided by neurological
departments at general hospitals. Sometime ‘an epilepsy centre’ or
‘epilepsy unit’ is a separate unit within a general or university
hospital, with a few beds (<10), especially for EEG monitoring.
People with permanent problems outside the direct ﬁeld of cure
generally reside in homes for people with mental or physicalhandicaps. It is important to note that this is the result of
developments elsewhere, resulting in the current situation. In the
period before 1900 for example, a dozen epilepsy centres existed in
the USA, such as the Ohio Hospital for epileptics, the Craig Colony in
New York and the Massachusetts Hospital for epileptics. These
institutions have all disappeared. The European Epilepsy centres
therefore represent those centres that were able to adapt over time,
taking on new roles and positions. Elsewhere such adaptation failed
or was not accepted by governments.
4. How to assess the current situation?
Sometimes history is seen as a progressive movement, a
development from ‘old fashioned’ to ‘modern’, from ‘poor’ to
‘enriched’. Even the title ‘from colony to community’ given tome for
this piece holds same connotation: from poor isolated individuals,
living deprived in asylums to the fortunate recipients of modern
medicine in the community.Wemust doubt, however, howmuchof
this is truewhenwereﬂect on the current situation for epilepsy care.
Of course it is preferable that epilepsy be treated ina local hospital in
the community, when that is possible. However, in those cases
where the epilepsy is complicated, seizure control is not achieved, or
co-morbidities occur, when epilepsy has long-term or even
permanent effects, a general hospital will lack the expertise and
the facilities for multidisciplinary cure and care. Treatment in a
general hospital ismono-disciplinary andwhen this fails the patient
is referred to another department: psychology, dermatology, etc.
(which does not necessarily have epileptological expertise). The
same is true for general facilities such as the laboratory or the
pharmacy: sufﬁcient for routine use, failing when speciﬁc expertise
is needed (which of course is not the role of a general pharmacy).
This is also a situation where epileptology as an expert function
can become neglected—as has been seen in many countries. In the
Netherlands, only one university hospital (Maastricht) has epilepsy
as its priority. In some countries no epilepsy centres exist and none
of the university hospitals have epilepsy as a specialism. In such a
situation epilepsy can become a condition that can only be treated
routinely. For those who do not need more than a repeat
prescription, that is ﬁne—but when seizures cannot be controlled,
when cognitive co-morbidities or depression develop, when
complicated side-effects occur, when difﬁcult treatments must be
used such a ketogenic diet, vagal nerve stimulation, deep brain
stimulation or epilepsy surgery, then this situation is less than
optimal. In such scenario, the emphasis on ‘epilepsy in the
community’ will reduce the options for specialized centres to
develop or to sustain themselves. Government policies, especially
budgetary policies, will follow this mainstream approach and will
emphasise the low-cost alternative of ‘treatment in general
hospitals’ in contrast to specialized care. This will deprive many
patients of the expertise and the facilities they need to treat their
epilepsy and its co-morbidities effectively and holistically.
In the previous section, it was noted that in addition to short
stay hospital facilities, most epilepsy centres also have a large
number of long-stay residential beds. Here also government
policies aim at moving from ‘colony to community’. These are
generally patients with severe refractory epilepsies and learning
disabilities. This begs the question—does it really help these people
to be transferred to homes for people with mental or physical
handicaps? The only difference for them is likely to be the lack of
facilities for optimal care of their epilepsy.
5. What is the future?
Epilepsy treatment and epilepsy care have developed consid-
erably over the years and the situation is completely different from
the time of the colonies with bromide, fresh air and labour as the
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than 15 different type of antiepileptic drugs, all with different
mechanisms of action, different indications, different effects on
seizures and different tolerability problems. Some of these drugs
are only effective for speciﬁc syndromes or may even aggravate
seizure frequency or seizure severity. As outlined in the papers by
Williams and Cross, there are different forms of the ketogenic diet;
there are also different forms of neuro-modulation, of which vagal
nerve stimulation is the most commonly used. As discussed by
Wilson and Engel, epilepsy surgery is available in most developed
countries and the type of surgery has developed from temporal
resections only to a spectrum of treatment techniques. Diagnostic
options have increased dramatically since the introduction of high
ﬁeldsmagnetic resonance imaging. There ismuchmore knowledge
about the impact of epilepsy on neurocognitive functions, and
there are options to prevent effects on learning and future
occupational possibilities. Social and psychological facilities have
been developed that are tailored to the needs of patients with
epilepsy.
Such complexity is not needed for every patient with epilepsy.
About 45% of newly diagnosed patientswill react favourably on the
ﬁrst antiepileptic drug, coming to and staying in remission.3 For
such patients neurological control in a general hospital is
sufﬁcient. However, the remaining large percentage of patients
need specialized epilepsy care in some form. Specialism and
expertise only develop with sufﬁcient critical mass. In other words
forms of centralized care in the formof epilepsy centreswill always
be necessary. This is not a plea to return to the colonies, but it is a
warning that the cry for ‘epileptology in the community’, when
translated as ‘epilepsy must be treated in general hospitals’, will
deprive the majority of the patients of specialized expertise and
care.
A disadvantage that the ‘older’ epilepsy centres in Europe have
is their disconnection from universities and university hospitals.
The claim of being ‘Centre of Competence’ and ‘Centre of
Excellence’ outside the facilities that have research, innovationand expertise as their core business is a weak point. Also in the
muchmore complex current situation it will be extremely difﬁcult
for such centres tomaintain all facilities (MRI, emergency facilities,
operation theatre) as state-of-the-art.
These problems can be solved by combining epilepsy centres
with university hospitals. In such a situation the epilepsy centre
becomes the epileptology specialism of the departments of
neurology and neurosurgery of a university hospital. This situation
guarantees specialized care, offers epileptology the critical mass to
develop further and connects it with the powerful resources for
research and innovation and with the high-tech possibilities in
university hospitals. This is actually the direction in which most of
the epilepsy centres in Europe are evolving: the combination of the
residential setting in Chalfont with hospital facilities (The National
Hospital for Neurology and Neurosurgery) and facilities and
university (Institute of Neurology of University College London)
was one of the ﬁrst examples, soon followed by similar
developments in Switzerland, Norway and the Netherlands.
Medical care: ‘from colonies to specialized academical centres
for epileptology, supplemented by good standard care in general
hospitals and in homes for patients with chronic epilepsy’ would
have been a too complex title for this article, but a much more
accurate one.
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